2021
DOI: 10.1093/ndt/gfab216
|View full text |Cite|
|
Sign up to set email alerts
|

Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease

Abstract: Metabolic acidosis, defined as a plasma or serum bicarbonate concentration <22 mmol/L, is a frequent consequence of chronic kidney disease (CKD) and occurs in ~10-30% of patients with advanced stages of CKD. Likewise, in patients with a kidney transplant, prevalence rates of metabolic acidosis range from 20% to 50%. CKD has recently been associated with cognitive dysfunction, including mild cognitive impairment with memory and attention deficits, reduced executive functions and morphological damage detectable … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 18 publications
(3 citation statements)
references
References 95 publications
0
3
0
Order By: Relevance
“…Patients with acute DoC due to uremic encephalopathy should undergo either IHD or CRRT to achieve metabolic clearance and neurologic reevaluation (51, 102). Patients taking valproic acid, or those with acute hepatic failure, may manifest hyperammonemia and benefit from gastrointestinal tract catharsis (i.e., lactulose) and luminal antibacterial therapy (i.e., rifaximin) to reduce potentially culpable metabolites (103, 104).…”
Section: Methodsmentioning
confidence: 99%
“…Patients with acute DoC due to uremic encephalopathy should undergo either IHD or CRRT to achieve metabolic clearance and neurologic reevaluation (51, 102). Patients taking valproic acid, or those with acute hepatic failure, may manifest hyperammonemia and benefit from gastrointestinal tract catharsis (i.e., lactulose) and luminal antibacterial therapy (i.e., rifaximin) to reduce potentially culpable metabolites (103, 104).…”
Section: Methodsmentioning
confidence: 99%
“…Moreover, it is possible that the metabolic acidosis that characterizes patients with CKD has an effect on cognitive ability, although there are currently few studies on this subject [42]. What is surprising, however, is the lack of correlation between the prevalence of MCI and that of metabolic acidosis, especially in the later stages of CKD [43]. The central nervous system might therefore operate an effective buffering system that prevents large changes in pH and mitigates the latter's cellular effects.…”
Section: Electrolyte Abnormalities and Acid-base Metabolismmentioning
confidence: 99%
“…However, they might suffer from depression [67]. Interestingly, no mild cognitive impairment has been reported in these patients, although it is often present in other forms of CKD [67][68][69][70][71][72][73]. Both PKD1 and PKD2 have large expression in the brain (data from Allen Brain Atlas database and from Human Protein Atlas database).…”
mentioning
confidence: 99%